Liver transplantation is a life-saving procedure for patients with end-stage liver disease, but survival after liver transplant is limited by preventable cardiovascular disease comorbidities and events. This project will benefit public health by developing a liver-transplant specific cardiovascular disease clinical practice guideline and then use principles of implementation science to implement the guideline in a pilot setting. The intervention developed will target improving cardiovascular disease outcomes among a high-risk population and maximize the benefit of scarce donated organs.
|Effective start/end date||9/1/17 → 6/30/21|
- National Heart, Lung, and Blood Institute (5K23HL136891-04)